Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 961 of 1,261
  1. US 7964186

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  2. US 7964573

    Regulating expression of transient receptor potential channel genes

    The Regents of the University of California · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  3. US 7964188

    Use of placental alkaline phosphatase to promote skin cell proliferation

    Essential Skincare, LLC · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  4. US 7964377

    Nucleic acid molecule encoding a fusion polypeptide capable of binding VEGF

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  5. US 7964591

    Pyridazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  6. US 7964559

    MVL, an antiviral protein from a cyanobacterium

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  7. US 7964561

    Protein formulations for use at elevated temperatures

    Advanced Technologies and Regenerative Medicine, LLC · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  8. US 7964576

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  9. US 2011142948

    Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy

    BIOLITEC INC [DE] · Granted Jun 16, 2011 · Expires Jun 11, 2031

    granted
  10. CA 2784005

    SYSTEMES DE VEHICULES NANOPARTICULAIRES A BASE DE POLY (ACIDE DL-LACTIQUE - CO - GLYCOLIQUE) (PLGA) POUR THERAPIE PHOTODYNAMIQUE (PDT)

    BIOLITEC PHARMA MARKETING LTD [MY] · Granted Jun 16, 2011 · Expires Jun 11, 2031

    granted
  11. US 7960348

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  12. US 7960505

    Lantibiotics and uses thereof

    Regents of the University of Minnesota · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  13. US 7960502

    Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

    Nektar Therapeutics · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  14. US 7960415

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  15. US 7960384

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  16. US 7960383

    Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  17. US 7960385

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  18. US 7959923

    Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA

    The Regents of the University of California · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  19. US 7960606

    Mouse model of chronic heart failure and coronary atherosclerosis regression

    The Regents of the University of California · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  20. US 7960416

    Stable emulsion composition

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  21. US 7960586

    Purification of armodafinil

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  22. US 7960535

    Recombinant lipidated PsaA protein, methods of preparation and use

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  23. US 7959934

    Method for rapid generation of mature dendritic cells

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  24. US 7959929

    Materials and methods for respiratory disease control in canines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.